NCT01489306

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled MDT-637 Administered to Healthy Volunteers for 10 Days

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: MicroDose Therapeutx, Inc · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to assess the tolerability and safety of a range of repeated inhaled doses of MDT-637. This includes monitoring effects on pulmonary function and determination of blood levels of MDT-637 following inhalation.

Conditions

• Drug Safety

Interventions

Type	Name	Description
DRUG	MDT-637	Inhaled doses of MDT-637 over a 10 day period
DRUG	MDT-637	Inhaled doses of MDT-637 over a 10 day period

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-02-01
• Completion: 2012-02-01
• First posted: 2011-12-09
• Last updated: 2012-04-12

Locations

1 site across 1 country: United States